ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,370,101 | -24.6% | 50,990 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,818,303 | +40.4% | 50,990 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $1,295,146 | -82.1% | 50,990 | -71.4% | 0.00% | -81.2% |
| Q4 2022 | $7,238,337 | +36.9% | 178,460 | +11.5% | 0.02% | +23.1% |
| Q3 2022 | $5,288,000 | +9.1% | 160,010 | +16.2% | 0.01% | +8.3% |
| Q2 2022 | $4,849,000 | +216.9% | 137,706 | +314.0% | 0.01% | +300.0% |
| Q1 2022 | $1,530,000 | -33.0% | 33,260 | -3.4% | 0.00% | -25.0% |
| Q4 2021 | $2,283,000 | -56.2% | 34,435 | -58.8% | 0.00% | -63.6% |
| Q3 2021 | $5,213,000 | -37.7% | 83,500 | -17.4% | 0.01% | -35.3% |
| Q2 2021 | $8,372,000 | +18.6% | 101,096 | -5.0% | 0.02% | +13.3% |
| Q1 2021 | $7,060,000 | -16.8% | 106,466 | -3.7% | 0.02% | -21.1% |
| Q4 2020 | $8,484,000 | +56.1% | 110,572 | -12.4% | 0.02% | +35.7% |
| Q3 2020 | $5,435,000 | +40.4% | 126,210 | +40.8% | 0.01% | +27.3% |
| Q2 2020 | $3,870,000 | +20.1% | 89,610 | -20.0% | 0.01% | 0.0% |
| Q1 2020 | $3,221,000 | -53.1% | 111,977 | +3.4% | 0.01% | -38.9% |
| Q4 2019 | $6,869,000 | – | 108,296 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |